Physician profile
Eric Goldsmith
NPI 1336131432
$5,496.11
in general payments reported to CMS, 2019-2025
8 companies · $66.50 in 2025
The $66.50 reported for 2025 was less than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $607 · 2020: $358 · 2021: $741 · 2022: $188 · 2023: $290 · 2024: $3,244 · 2025: $66.50.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,060 · Food and Beverage: $541.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,060.00 |
| Food and Beverage | $540.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Almatica Pharma LLC | $3,363.62 | 2021-2025 | Loreev Xr, Sertraline Hcl |
| Abbvie INC. | $615.64 | 2021-2023 | |
| Allergan, INC. | $509.67 | 2019-2020 | |
| Lundbeck LLC | $499.64 | 2020-2024 | Rexulti |
| Takeda Pharmaceuticals U.S.A., INC. | $452.25 | 2019-2022 | |
| Axsome Therapeutics, INC. | $22.77 | 2025 | Auvelity |
| Sunovion Pharmaceuticals INC. | $16.87 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $15.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Goldsmith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.